Sunil Kumar Kadiri – författare

Alzheimer’s disease (AD) stands as a profound and growing global health concern, characterized by progressive neurodegeneration and cognitive decline. As research into the underlying causes of AD advances, it becomes clear that a deeper understanding of its molecular mechanisms is crucial for the development of effective therapeutic interventions. This new two-volume set, Cellular and Molecular Mechanism in Alzheimer’s Disease Therapeutics, presents a detailed exploration of the cellular and molecular processes that drive the onset and progression of Alzheimer’s disease. The volume brings together leading experts who offer insights into the intricate cellular and molecular pathways involved in AD pathology as well as potential therapeutic targets and innovative treatment strategies.Volume 1: Cellular Mechanism in Alzheimer’s Disease Therapeutics presents a detailed and up-to-date exploration of the cellular processes involved in AD, with an emphasis on their implications for therapeutic interventions. The book offers a comprehensive understanding of how various cellular mechanisms, such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation, contribute to the pathology of disease. Topics include blood-brain barrier dysfunction in AD, personalized medicine approaches based on genetic profiling, microRNAs in the management of disease, and more.Volume 2: Molecular Mechanism in Alzheimer’s Disease Therapeutics provides a comprehensive understanding of the disease at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to the disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. The volume presents some emerging tools and novel therapeutics and also discusses pharmacological modulation of neurodegenerative disorders, behavioral intervention and cognitive training in AD management, customizing therapies to individual genetic and molecular characteristics, ethical considerations in clinical trials and research, international efforts in AD research and treatment, and more. This volume bridges the gap between molecular research and therapeutic applications, shedding light on the latest findings related to disease mechanisms, such as oxidative stress, synaptic alterations, and the role of neuroinflammatory pathways.Unlike other texts, these two volumes integrate the latest research on biomarkers, drug development, and innovative treatment strategies, offering a comprehensive and up-to-date resource. The unique focus on both fundamental science and practical therapeutic applications makes this two-volume set an invaluable guide for researchers, clinicians, and students aiming to advance their understanding and treatment of disease. By focusing on the cellular and molecular insights into this disease, these volumes pave the way for inspiring novel therapeutic approaches that address the root causes of neurodegeneration.

Alzheimer’s disease (AD) stands as a profound and growing global health concern, characterized by progressive neurodegeneration and cognitive decline. As research into the underlying causes of AD advances, it becomes clear that a deeper understanding of its molecular mechanisms is crucial for the development of effective therapeutic interventions. This new two-volume set, Cellular and Molecular Mechanism in Alzheimer’s Disease Therapeutics, presents a detailed exploration of the cellular and molecular processes that drive the onset and progression of Alzheimer’s disease. The volume brings together leading experts who offer insights into the intricate cellular and molecular pathways involved in AD pathology as well as potential therapeutic targets and innovative treatment strategies.Volume 1: Cellular Mechanism in Alzheimer’s Disease Therapeutics presents a detailed and up-to-date exploration of the cellular processes involved in AD, with an emphasis on their implications for therapeutic interventions. The book offers a comprehensive understanding of how various cellular mechanisms, such as synaptic dysfunction, neuroinflammation, mitochondrial impairment, and protein aggregation, contribute to the pathology of disease. Topics include blood-brain barrier dysfunction in AD, personalized medicine approaches based on genetic profiling, microRNAs in the management of disease, and more.Volume 2: Molecular Mechanism in Alzheimer’s Disease Therapeutics provides a comprehensive understanding of the disease at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to the disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. The volume presents some emerging tools and novel therapeutics and also discusses pharmacological modulation of neurodegenerative disorders, behavioral intervention and cognitive training in AD management, customizing therapies to individual genetic and molecular characteristics, ethical considerations in clinical trials and research, international efforts in AD research and treatment, and more. This volume bridges the gap between molecular research and therapeutic applications, shedding light on the latest findings related to disease mechanisms, such as oxidative stress, synaptic alterations, and the role of neuroinflammatory pathways.Unlike other texts, these two volumes integrate the latest research on biomarkers, drug development, and innovative treatment strategies, offering a comprehensive and up-to-date resource. The unique focus on both fundamental science and practical therapeutic applications makes this two-volume set an invaluable guide for researchers, clinicians, and students aiming to advance their understanding and treatment of disease. By focusing on the cellular and molecular insights into this disease, these volumes pave the way for inspiring novel therapeutic approaches that address the root causes of neurodegeneration.

This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications.